VCM
LENZ

Voleon Capital Management’s LENZ Therapeutics LENZ Stock Holding History

Voleon Capital Management’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$274K Buy
+29,992
New +$421K 0.01% 681
2025
Q4 		– Sell
-8,591
Closed -$400K – 1054
2025
Q3 		$400K Buy
+8,591
New +$316K 0.01% 643

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Voleon Capital Management's LENZ Position: Q1 2026 in Review

Voleon Capital Management opened a new position in LENZ Therapeutics (LENZ) in Q1 2026: 29,992 shares worth $274K. The stake represents 0.01% of the portfolio and ranks #681 among its holdings. This is a return to the name: Voleon Capital Management previously reported a position in LENZ as recently as Q3 2025.

Voleon Capital Management first reported a position in LENZ in Q3 2025 and has held it in 2 quarters since. The position peaked at $400K in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Voleon Capital Management held 29,992 shares of LENZ Therapeutics worth $274K as of Q1 2026.
  • LENZ Therapeutics was a new Voleon Capital Management position in Q1 2026.
  • LENZ Therapeutics made up 0.01% of Voleon Capital Management's portfolio in Q1 2026, its #681 holding.
  • Voleon Capital Management first reported a position in LENZ Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • Voleon Capital Management's LENZ Therapeutics position peaked at $400K in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.